Dr. Shreya Kanth is a clinical investigator in the Critical Care Medicine and Pulmonary Branch at the National Institutes of Health. After completing her undergraduate degree in Biomedical Engineering at Virginia Commonwealth University, she received her medical degree from The University of Virginia School of Medicine, completed her residency in Internal Medicine at the University of Pittsburgh Medical Center, followed by fellowships in Critical Care Medicine at NIH and Pulmonary Medicine at the University of Maryland.

In addition to her clinical service on the Pulmonary Consult Service and in the Intensive Care Unit at the NIH, she is conducting translational and basic science research characterizing mechanisms underlying recovery from acute lung injury using high density proteomics to phenotype patients and identify novel targetable pathways.

Dr. Kanth will be presenting her research on how the lung microbiome changes over time following recovery from SARS CoV-2 infection and will also discuss future research aimed at modulating the pulmonary microbiome to improve management of different lung diseases.